What to Expect at Your NK Cell Therapy Consultation in Japan

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Interest in advanced immunotherapies like Natural Killer (NK) cell therapy is growing worldwide. For those considering this treatment in Japan, the first and most crucial step is the initial medical consultation. This meeting is far more than a simple introduction; it is a comprehensive medical assessment where a physician determines if NK cell therapy is a suitable option for your specific health condition and goals.

This article explains what happens during this initial consultation, what medical information is evaluated, and how a personalized treatment plan is developed. The primary goal is to conduct a thorough medical evaluation to see if you are an appropriate candidate. A physician will carefully review your medical history, current health status, and previous treatment records to make an informed judgment. Based on this detailed assessment, a potential treatment plan tailored to your individual needs can be proposed.

Why the Initial Consultation is Crucial

When considering a specialized treatment like NK cell therapy, it’s natural to have many questions. The initial consultation is designed to address these concerns and provide clarity. Patients often wonder:

• Am I a suitable candidate for this therapy?
• What specific medical records and test results do I need to provide?
• How is a personalized treatment plan created based on my condition?
• What are the potential benefits, risks, and side effects I should be aware of?

This first meeting is the cornerstone of determining immunotherapy eligibility. It is a critical step where a physician performs a detailed cancer treatment assessment, ensuring that any subsequent decisions are based on solid medical evidence and aligned with your personal health situation.

Key Medical Information Reviewed by Your Physician

To determine eligibility for NK cell therapy, a physician needs a complete picture of your health. This is not a one-size-fits-all treatment, and a careful, evidence-based approach is essential. The evaluation typically involves a review of several key areas:

Medical History and Treatment Records

Your doctor will need to understand your entire cancer treatment journey. This includes your initial diagnosis, the cancer type and stage, and a detailed history of all treatments you have received, such as surgery, chemotherapy, or radiation therapy. Information on how you responded to these treatments and any side effects you experienced is also vital. This history helps the physician assess whether NK cell therapy could be a complementary option to your existing or past treatments.

Current Blood Tests and Imaging Scans

Objective data is fundamental to the assessment. Recent blood test results provide insight into your overall health, including organ function (liver, kidneys) and blood cell counts. They also offer clues about the state of your immune system. Imaging reports from CT, MRI, or PET scans are used to evaluate the current status and location of any tumors. This information helps establish a baseline and understand the present state of the disease.

Assessment of General Health and Performance Status

Your overall physical condition, often measured by a scale like the ECOG Performance Status, is another critical factor. This assessment helps determine if your body is strong enough to undergo treatment. The physician will consider your daily activity level, symptoms, and overall well-being to ensure that the therapy is a viable option for you.

Developing Your Personalized NK Cell Therapy Plan

After a thorough review of your medical information, the physician can determine if NK cell therapy is appropriate for you. If it is considered a suitable option, the next step is to develop a personalized treatment plan. This plan is tailored to your specific situation and treatment goals. For example, the objective might be to prevent recurrence after standard treatment, to be used in combination with other therapies, or to help manage the disease and support quality of life. The proposed schedule, including the number and frequency of infusions, will be discussed in detail. It is important to understand that this is a collaborative process. The physician will explain the reasoning behind the proposed plan, the expected outcomes, and the potential risks or side effects, allowing you to provide informed consent before proceeding.

How to Prepare for Your Consultation in Osaka

To make your initial medical consultation as effective as possible, it is helpful to come prepared. Gathering the necessary medical documents in advance can streamline the process and allow for a more productive discussion with the physician at our Osaka clinic.

• Medical Records for Cancer Therapy: A summary of your diagnosis and treatment history from your current or previous doctor is essential. If you are traveling from abroad, having these documents translated into English can be very helpful.
• Test Results: Bring recent copies of blood work, pathology reports, and any other relevant laboratory tests.
• Imaging Data: Provide recent imaging scans (e.g., CT, MRI, PET) on a CD-ROM or other digital format, along with the corresponding radiologist’s report.
• List of Questions: Write down any questions or concerns you have ahead of time. This ensures you remember to discuss everything that is important to you.

Understanding NK Cell Therapy at Grand Green Osaka Umekita Clinic

At Grand Green Osaka Umekita Clinic, we provide NK cell therapy under a treatment plan submitted to and accepted by Japan’s Ministry of Health, Labour and Welfare, in accordance with the Act on the Safety of Regenerative Medicine. This therapy involves collecting your own NK cells from a blood draw, activating and expanding them in a specialized facility, and then returning them to your body via an IV infusion.

It is important to note that this treatment is provided as private, uninsured medical care (not covered by national health insurance). The final decision on whether you are a suitable candidate can only be made after a comprehensive assessment by a physician. During your consultation, the doctor will provide a full explanation of the treatment process, including the expected number of sessions, duration, costs, as well as potential risks and side effects. For general information, please see our dedicated page.

Conclusion: Your First Step Toward an Informed Decision

The initial medical consultation is the foundational step in exploring NK cell therapy. It is a vital dialogue between you and your physician, designed to ensure that any treatment path chosen is appropriate and personalized to your unique medical circumstances. By understanding your health history and current condition through a comprehensive review of your medical records, a doctor can help you navigate your options. All treatment decisions must be based on a physician’s professional judgment. If you are considering cancer immunotherapy in Japan, we welcome you to schedule a consultation at our clinic in Umeda, Osaka, to discuss your situation.

1. 1Prepare Medical RecordsBring records, test results, and imaging data
2. 2Medical ConsultationPhysician assesses your eligibility
3. 3Personalized Treatment PlanA plan tailored to your condition and goals
4. 4NK Cell InfusionCultured NK cells are returned to your body

This is a conceptual diagram to summarize the content of the article

References

• PMC: Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation. (2024)
• PMC: Efficacy and safety of natural killer cell therapy for the treatment of advanced non-small cell lung cancer: A meta-analysis and systematic review. (2025)
• PMC: Abstracts From the 49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12-15, 2017. (2017)
• PMC: Comparative Effectiveness of Ascorbic Acid vs. Calcium Ascorbate Ingestion on Pharmacokinetic Profiles and Immune Biomarkers in Healthy Adults: A Preliminary Study. (2024)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.